Literature DB >> 30729532

Risk of HPA-1a-immunization in HPA-1a-negative women after giving birth to an HPA-1a-positive child.

Jens Kjeldsen-Kragh1,2, Klaus Juel Olsen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30729532     DOI： 10.1111/trf.15152

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  3 in total

1.  Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome.

Authors:  Jens Kjeldsen-Kragh; Dean A Fergusson; Mette Kjaer; Lani Lieberman; Andreas Greinacher; Michael F Murphy; James Bussel; Tamam Bakchoul; Stacy Corke; Gérald Bertrand; Dick Oepkes; Jillian M Baker; Heather Hume; Edwin Massey; Cecile Kaplan; Donald M Arnold; Shoma Baidya; Greg Ryan; Helen F Savoia; Denise Landry; Nadine Shehata
Journal:  Blood Adv       Date:  2020-07-28

2.  HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.

Authors:  Jens Kjeldsen-Kragh; Thomas L Titze; Benedicte Alexandra Lie; John T Vaage; Mette Kjær
Journal:  Blood Adv       Date:  2019-04-09

Review 3.  Noninvasive Prenatal Testing in Immunohematology-Clinical, Technical and Ethical Considerations.

Authors:  Jens Kjeldsen-Kragh; Åsa Hellberg
Journal:  J Clin Med       Date:  2022-05-19       Impact factor: 4.964
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.